Department of Urinary Surgery, The Affiliated Tumor Hospital, Harbin Medical University, Harbin, China.
Intern Med J. 2012 Jun;42(6):e115-9. doi: 10.1111/j.1445-5994.2011.02434.x.
MicroRNAs (miRNAs) are small non-coding RNAs with regulatory functions as tumour suppressors and oncogenes. Although single nucleotide polymorphism (SNP) in miRNA regions have been reported to be rare and unlikely to be functionally important, recent evidence suggested that rs11614913 SNP in miR-196a2 was associated with the susceptibility of lung cancer, breast cancer, congenital heart disease and shortened survival time of non-small-cell lung cancer.
The aim of this study was to investigate the association between this genetic variant and the risk and/or progression of colorectal cancer (CRC).
A total of 126 CRC patients and 407 healthy controls was periodically enrolled. DNA was extracted from blood specimens, and miR-196a2 polymorphism was genotyped by polymerase chain reaction-ligation detection reaction (PCR-LDR).
Although the frequency of CC homozygotes or miR-196a2C allele-containing genotypes (CT and CC) was lower in CRC patients than in the healthy controls, no significant association between miR-196a2 polymorphism and the risk of CRC was found. The frequency of the 'C' allele in CRC patients was also not significantly lower than in healthy controls. In a subsequent analysis of the association between this polymorphism and the progression of CRC, there was still no significant difference in both genotype and allelic frequency.
Our results suggest that miR-196a2 polymorphism is not associated with both an increased risk and progression of CRC in Chinese.
微小 RNA(miRNAs)是具有调节功能的小非编码 RNA,作为肿瘤抑制因子和癌基因。尽管 miRNA 区域的单核苷酸多态性(SNP)很少且不太可能具有重要的功能,但最近的证据表明,miR-196a2 中的 rs11614913 SNP 与肺癌、乳腺癌、先天性心脏病和非小细胞肺癌患者的生存时间缩短有关。
本研究旨在探讨该遗传变异与结直肠癌(CRC)的风险和/或进展之间的关系。
定期招募了 126 名 CRC 患者和 407 名健康对照者。从血液标本中提取 DNA,并通过聚合酶链反应-连接检测反应(PCR-LDR)对 miR-196a2 多态性进行基因分型。
尽管 CRC 患者中 CC 纯合子或 miR-196a2C 等位基因(CT 和 CC)的频率低于健康对照组,但 miR-196a2 多态性与 CRC 的风险之间没有显著关联。CRC 患者中“C”等位基因的频率也明显低于健康对照组。在随后对该多态性与 CRC 进展之间的关系进行的分析中,基因型和等位基因频率也没有显著差异。
我们的结果表明,miR-196a2 多态性与中国人群 CRC 的风险增加和进展无关。